Effect of Propionyl-L-Carnitine on Quality of Life in Intermittent Claudication

How should we measure function in patients with chronic heart and lung disease?

Gordon Guyatt, Penelope J. Thompson, Leslie B. Berman et al. · Journal of Chronic Diseases · 1985 · 436 citations

Heart Failure, Pulmonary Care, Cardiovascular Disease +12

The McMaster Health Index Questionnaire as a measure of quality of life for patients with rheumatoid disease.

L W Chambers, Logan Macdonald, Peter Tugwell et al. · PubMed · 1983 · 213 citations

Rheumatoid Disorder, Rheumatology, Quality Of Life +8

The development and application of indices of health: general methods and a summary of results.

David L. Sackett, L W Chambers, A S MacPherson et al. · American Journal of Public Health · 1977 · 137 citations · Full text

Quality Of Life, Family Medicine, Life Assessment +17

Propionyl-l-carnitine in intermittent claudication: Double-blind, placebo-controlled, dose titration, multicenter study

Gregorio Brevetti, Sergio Perna, Carlo Sabbà et al. · Journal of the American College of Cardiology · 1995 · 114 citations

Medicine, Dose Titration, Pharmacotherapy +2

Superiority of L-propionylcarnitine vs L-carnitine in improving walking capacity in patients with peripheral vascular disease: an acute, intravenous, double-blind, cross-over study

Gregorio Brevetti, Stefano Perna, Carlo Sabbà et al. · European Heart Journal · 1992 · 98 citations